DuPont de Nemours Inc vs Gitlab Inc — how do they compare? DuPont de Nemours Inc trades at $131.75 (market cap $17.89B), while Gitlab Inc trades at $53.89 (market cap $8.92B). The key difference: DuPont de Nemours Inc is far larger — about 2× Gitlab Inc's market cap, and DuPont de Nemours Inc pays a 1.81% dividend while Gitlab Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold DuPont de Nemours Inc for 89 Days and Gitlab Inc for 62 Days on average.
| DD | GTLB | |
|---|---|---|
Market Cap | $17.89B | $8.92B |
Volume | 816,409 | 4,716,893 |
Sector | Basic Materials | Technology |
52-Week High | $154.59 | $53.56 |
52-Week Low | $92.49 | $19.42 |
Typical Hold Time | 89 Days | 62 Days |
Enterprise Value | $19.28B | $7.66B |
Dividend Yield | 1.81% | — |
Signals from Pluang's Aura AI — not financial advice
DuPont (DD) trades at $131.08, down 1.65% on the day, with neutral technical signals from moving averages and oscillators. The company shows mixed fundamentals with recent earnings beats but declining revenue from $12.4B in 2024 to $6.85B in 2025, resulting in a net loss of $779M. Analyst sentiment remains positive with 58.5% buy ratings, though the consensus price target of $95 suggests caution. Recent developments include new product launches in sugar separation technology and Tyvek innovations, alongside ongoing PFAS litigation settlements.
The outlook for DD hinges on margin recovery and growth in key sectors like healthcare and water technologies, but investors face risks from legal liabilities, volatile cash flows, and high P/E valuation. Institutional activity shows mixed signals with both position reductions and significant increases, reflecting uncertainty about near-term performance amid structural growth opportunities.
GitLab (GTLB) trades at $51.99, up 0.7% with strong bullish technical momentum. The stock shows impressive revenue growth from $759M in 2025 to projected $1.1B in 2026, though profitability remains challenged with a -4.99% net margin. Recent Q2 2026 earnings beat expectations with $0.24 EPS versus $0.18 expected, driving positive sentiment. The company's AI-driven DevSecOps platform is gaining traction, with agentic automation features and Flex bookings showing strong momentum according to recent earnings calls.
Outlook remains cautiously optimistic with 36.7% analyst buy ratings but elevated valuation metrics (P/E 521, P/S 8.3) present risk. Key opportunities include AI product adoption and enterprise expansion, while risks center on profitability timeline and competitive pressures. The consensus price target of $49.71 suggests limited upside from current levels despite recent operational improvements.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics and communication, automotive, construction, safety and protection, and water management industries. DuPont benefits from the ability to produce patented specialty chemicals that command pricing power. Noteworthy products include Kevlar, Tyvek, and Nomex have evolved over time to enable a wide range of applications across multiple industries.
Read more on DD →GitLab Inc operates on an all-remote model. The company is a technology company whose primary offering is GitLab, a complete DevOps platform delivered as a single application. GitLab is used by a wide range of organizations. The company also provides related training and professional services. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. The principal markets for GitLab are currently located in the United States, Europe, and Asia Pacific. The company is focused on accelerating innovation and broadening the distribution of its platform to companies across the world.
Read more on GTLB →